Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global autoinjector market attained a value of USD 1.78 billion in 2020. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 18.10% to reach USD 4.85 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, disposable autoinjectors account for a significant market share of the global autoinjector industry. This can be attributed to their ease of use and the presence of a built-in glass syringe, which eliminates the need for patients with limited dexterity or vision impairments to manually load the glass syringe, making the process more comfortable for them.
As a result, an increase in preference for disposable autoinjectors is expected to aid the market growth. Furthermore, the growing prevalence of rheumatoid arthritis is expected to drive the product demand in the forecast period.
The Asia Pacific region is expected to witness a rapid growth in the forecast period, indicating a significant potential to contribute to the global autoinjector industry growth. Because of the high prevalence of diabetes and growing healthcare expenditures, a number of prominent autoinjector device manufacturers are being attracted to this region, adding to the market growth. These companies are expanding their presence through a variety of means, including creating sales offices and forming alliances with local pharmaceutical companies, which is expected to drive the growth of the Asia Pacific autoinjector industry in the coming years.
An autoinjector is a medical device that consists of a syringe with a spring-loaded needle and a pre-filled drug dose. Autoinjectors are commonly used to avoid anaphylaxis and provide rapid pain relief. Autoinjectors provide a number of advantages, including reducing needle-related anxiety condition, reducing the danger of needle-stick incidents, assuring dose quality consistency, and assisting with increased efficacy.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By type, the industry is segmented into:
The market can be broadly categorised on the basis of its application into:
The EMR report looks into the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The autoinjector industry is expected to grow considerably in the coming years due to the growing anaphylactic cases globally. As the first line of defence, epinephrine is used to treat anaphylaxis. Innovative designs and portable devices such as autoinjectors with two auto injectable doses in one device and epinephrine with improved temperature stability and shelf life are expected to contribute to the market expansion. Furthermore, the market is expected to grow as a result of the increased efforts by key players in product development, such as the creation of autoinjectors with easy, cost-effective, and cutting-edge technology for the treatment of chronic diseases. The government policies for favourable reimbursements as well as the rapid technological advancements, such as dosage monitoring, are other growth drivers for the industry.
The report presents a detailed analysis of the following key players in the global autoinjector market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, Region |
Breakup by Type | Disposable, Reusable |
Breakup by Application | Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Amgen Inc., Antares Pharma, Inc., Becton, Dickinson and Company, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Autoinjector Market Analysis
8.1 Key Industry Highlights
8.2 Global Autoinjector Historical Market (2018-2022)
8.3 Global Autoinjector Market Forecast (2023-2028)
8.4 Global Autoinjector Market by Type
8.4.1 Disposable
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Reusable
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Autoinjector Market by Application
8.5.1 Rheumatoid Arthritis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Multiple Sclerosis
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Anaphylaxis
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Autoinjector Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Amgen Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Antares Pharma, Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Becton, Dickinson and Company
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Autoinjector Market: Key Industry Highlights, 2018 and 2028
2. Global Autoinjector Historical Market: Breakup by Type (USD Billion), 2018-2022
3. Global Autoinjector Market Forecast: Breakup by Type (USD Billion), 2023-2028
4. Global Autoinjector Historical Market: Breakup by Application (USD Billion), 2018-2022
5. Global Autoinjector Market Forecast: Breakup by Application (USD Billion), 2023-2028
6. Global Autoinjector Historical Market: Breakup by Region (USD Billion), 2018-2022
7. Global Autoinjector Market Forecast: Breakup by Region (USD Billion), 2023-2028
8. North America Autoinjector Historical Market: Breakup by Country (USD Billion), 2018-2022
9. North America Autoinjector Market Forecast: Breakup by Country (USD Billion), 2023-2028
10. Europe Autoinjector Historical Market: Breakup by Country (USD Billion), 2018-2022
11. Europe Autoinjector Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Asia Pacific Autoinjector Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Asia Pacific Autoinjector Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Latin America Autoinjector Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Latin America Autoinjector Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Middle East and Africa Autoinjector Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Middle East and Africa Autoinjector Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Global Autoinjector Market Structure
In 2020, the global autoinjector market attained a value of nearly USD 1.78 billion.
The market is projected to grow at a CAGR of 18.10% between 2023 and 2028.
The major industry drivers include the increasing developments in autoinjector design, increased investment in the health care industry, increasing government assistance for favourable reimbursements, increase in preference for disposable autoinjectors and growing prevalence of rheumatoid arthritis.
The key industry trends for global autoinjector industry are the growing anaphylactic cases and increased efforts by key players in product development, such as the creation of autoinjectors with easy, cost-effective, and cutting-edge technology for the treatment of chronic diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with Asia Pacific accounting for the significant share in the market.
The significant type of autoinjector available in the industry are disposable and reusable.
The significant segments of the industry on the basis of application are rheumatoid arthritis, multiple sclerosis, and anaphylaxis, among others.
The major players in the industry are Amgen Inc., Antares Pharma, Inc., and Becton, Dickinson and Company, among others.
The global autoinjector market attained a value of USD 1.78 billion in 2020, driven by the growing anaphylactic cases . Aided by developing technologically enhanced epinephrine autoinjectors (EAIs) to cure anaphylaxis and increasing government assistance for favourable reimbursements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 18.10%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on types, the industry can be segmented into disposable and reusable. On the basis of applications, the market is divided into rheumatoid arthritis, multiple sclerosis, and anaphylaxis, among others. The major regional markets for autoinjector are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with Asia Pacific accounting for the largest share of the market. The key players in the above market include Amgen Inc., Antares Pharma, Inc., and Becton, Dickinson and Company, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.